2,4,6-trichloro-N-methylbenzenamine | 35114-02-4

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 2,4,6-trichloro-N-methylbenzenamine
• 英文别名: 2,4,6-trichloro-N-methyl-aniline；2,4,6-Trichlor-N-methyl-anilin；N-Methyl-2,4,6-trichloroaniline；2,4,6-trichloro-N-methylaniline
• CAS: 35114-02-4
• 化学式: C₇H₆Cl₃N
• 分子量: 210.49
• InChiKey: QHXFGOIOVYTMHQ-UHFFFAOYSA-N

物化性质

• 沸点：
  134-137 °C(Press: 25 Torr)
• 密度：
  1.454±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  12
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2921420090

反应信息

• 作为反应物：
  描述：

  2,4,6-trichloro-N-methylbenzenamine 在 chromium(VI) oxide 作用下， 生成 2,4,6-三氯苯胺
  参考文献：
  名称：

  Hentschel, Chemische Berichte, 1897, vol. 30, p. 2647

  摘要：

  DOI：
• 作为产物：
  描述：

  2,4,6-trichloro-N-methyl-N-nitroso-aniline 在 盐酸 、 tin(ll) chloride 作用下， 生成 2,4,6-trichloro-N-methylbenzenamine
  参考文献：
  名称：

  Methylanilines by Demethylation of Dimethylanilines

  摘要：

  DOI：

  10.1021/ja01852a502

文献信息

• CFBSA: a novel and practical chlorinating reagent
  作者：Zehai Lu、Qingwei Li、Minghua Tang、Panpan Jiang、Hao Zheng、Xianjin Yang

  DOI：10.1039/c5cc05052a

  日期：——

  A novel chlorinating reagent was synthesized from easily-obtained materials and it shows great reactivity to a large scope of substrates.

  一个新型氯化试剂是由易得材料合成的，对广泛范围的底物表现出很高的反应性。
• [EN] NOVEL SULFONYLAMINOBENZAMIDE COMPOUNDS AS ANTHELMINTICS<br/>[FR] NOUVEAUX COMPOSÉS SULFONYLAMINOBENZAMIDE UTILISÉS COMME ANTHELMINTIQUES
  申请人：NOVARTIS TIERGESUNDHEIT AG

  公开号：WO2016033341A1

  公开（公告）日：2016-03-03

  The present invention relates to a new compound of formula (I) wherein the variables have the meaning as indicated in the claims; or an enantiomer or salt thereof. The compounds of formula (I) are useful in the control of parasites, in particular endoparasites, in and on vertebrates.

  本发明涉及一种新的化合物，其化学式为（I），其中变量的含义如索赔中所示；或其对映体或盐。化合物的化学式（I）在控制寄生虫方面具有用途，特别是在脊椎动物体内和体外的内寄生虫。
• [EN] 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS<br/>[FR] COMPOSES 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE POUR LE TRAITEMENT DE LA TUBERCULOSE
  申请人：OTSUKA PHARMA CO LTD

  公开号：WO2005042542A1

  公开（公告）日：2005-05-12

  The present invention provides a 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound represented by the following general formula: (1)in the above formula (1), R1 represents a hydrogen atom or C1-C6 alkyl group, n represents an integer of 0 to 6, R1 and -(CH2)nR2 may form a spiro ring represented by the formula (30) below, together with the adjacent carbon atom (in the formula below, RRR represents a piperidyl group which may have substituents on the piperidine ring), (30)and R2 represents a benzothiazolyloxy group, quinolyloxy group, pyridyloxy group or the like. The present compound has an excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria.

  本发明提供了一种由以下一般式表示的2,3-二氢-6-硝基咪唑[2,1-b]噁唑化合物：(1)在上述式(1)中，R1代表氢原子或C1-C6烷基，n代表0至6的整数，R1和-(CH2)nR2可以与下面的式(30)一起形成一个螺环，与相邻的碳原子一起（在下面的式中，RRR代表可能在哌啶环上具有取代基的哌啶基），(30)和R2代表苯并噻唑氧基、喹啉氧基、吡啶氧基或类似物。该化合物对结核分枝杆菌、多药耐药结核分枝杆菌和非典型耐酸细菌具有出色的杀菌作用。
• Opioid compounds and methods for making therefor
  申请人：Delta Pharmaceuticals, Inc.

  公开号：US05574159A1

  公开（公告）日：1996-11-12

  Diarylmethyl piperazine compounds having utility as exogenous receptor combinant species for binding with receptors such as delta, mu, sigma, and/or kappa receptors are disclosed. Compounds of the invention may be employed as conjugates in agonist/antagonist pairs for transductional monitoring and assays of neurotransmitter function, and also variously exhibit therapeutic utility, including mediating analgesia, and possessing utility for the treatment of diarrhea, urinary incontinence, mental illness, drug and alcohol addiction/overdose, lung edema, depression, asthma, emphysema, cough, and apnea, respiratory depression, cognitive disorders, emesis and gastrointestinal disorders.

  本发明揭示了具有外源性受体结合物种功能的二芳甲基哌嗪化合物，用于与δ、μ、σ和/或κ受体结合。本发明的化合物可作为激动剂/拮抗剂对中的共轭物，在神经递质功能的传导监测和检测中使用，并且也具有各种治疗效用，包括介导镇痛，并具有治疗腹泻、尿失禁、精神疾病、药物和酒精成瘾/过量、肺水肿、抑郁症、哮喘、肺气肿、咳嗽和呼吸暂停、呼吸抑制、认知障碍、呕吐和胃肠疾病的功效。
• 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis
  申请人：Tsubouchi Hidetsugu

  公开号：US20080119478A1

  公开（公告）日：2008-05-22

  The present invention provides a 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound represented by the following general formula: (1) in the above formula (1), R1 represents a hydrogen atom or C1-C6 alkyl group, n represents an integer of 0 to 6, R1 and —(CH2) n R2 may form a spiro ring represented by the formula (30) below, together with the adjacent carbon atom (in the formula below, RRR represents a piperidyl group which may have substituents on the piperidine ring), (30) and R2 represents a benzothiazolyloxy group, quinolyloxy group, pyridyloxy group or the like. The present compound has an excellent bactericidal action against Mycobacterium tuberculosis , multi-drug-resistant Mycobacterium tuberculosis , and atypical acid-fast bacteria.

  本发明提供了一种由下述通式（1）表示的2,3-二氢-6-硝基咪唑[2,1-b]噁唑化合物： 在上述式（1）中，R1代表氢原子或C1-C6烷基，n代表0到6的整数，R1和—(CH2)nR2可以与相邻的碳原子形成如下式（30）所示的螺环，其中，在下式中，RRR代表可能在哌啶环上具有取代基的哌啶基： （30）且R2代表苯并噻唑氧基、喹啉氧基、吡啶氧基或类似基团。该化合物对结核分枝杆菌、多重耐药结核分枝杆菌和非典型酸杆菌具有优异的杀菌作用。